Attovia Therapeutics, Inc. carries a market capitalization of 1.10B, placing it among publicly traded companies globally.
| Market Cap | 1.10B |
| Enterprise Value | N/A |
Attovia Therapeutics, Inc.'s stock has gained approximately 16.66667% over the past 52 weeks. The 50-day moving average sits at 20.90, while the 200-day moving average is 20.90.
| Beta (5Y) | N/A |
| 52-Week Price Change | 16.66667% |
| 50-Day Moving Average | 20.90 |
| 200-Day Moving Average | 20.90 |
| Average Volume (20 Days) | N/A |
Attovia Therapeutics, Inc.'s most recent stock split took place on July 30, 2020 with a 5:1 split ratio.
| Last Split Date | 7/30/2020 |
| Split Ratio | 5:1 |